StonvexLoading…
StonvexStonvexStonvexCore line items from WAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $135.80M | $68.00M | $98.60M | $44.10M |
Operating Income | $1.21B | $991.20M | $933.60M | $1.32B |
Net Income | $969.00M | $787.70M | $722.40M | $1.06B |
EPS (Diluted) | $8.73 | $7.09 | $6.54 | $9.70 |
Total Assets | $92.77B | $80.93B | $70.86B | $67.73B |
Total Liabilities | $84.83B | $74.23B | $64.78B | $62.38B |
Cash & Equivalents | $3.60B | $4.10B | $1.58B | $1.04B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 109.50M | 109.30M | 108.50M | 107.60M |